Abstract: The use of IL-22 for the treatment of metabolic disorders including hyperlipidemia, obesity, hyperinsulinemia and diabetes. IL-22 may also be used in combination with insulin for diabetes.

Abstract: A substantially pure and biologically active peptides consisting of tyrosyl-seryl-leucine (YSL) is disclosed. Nucleic acids that have sequences coding for the biologically active peptide and pharmaceutical formulation produced therefrom are also disclosed.

Abstract: The use of IL-22 for the treatment of metabolic disorders including hyperlipidemia, obesity, hyperinsulinemia and diabetes. IL-22 may also be used in combination with insulin for diabetes.

Abstract: The tripeptide Tyrosyl-seryl-valine is disclosed with its use as a nutritional supplement. A method of making a nutritional supplement comprising obtaining the tripeptide Tyrosyl-seryl-valine and mixing the tripeptide with a biologically or therapeutically acceptable carrier is also disclosed.

Abstract: A method and system for capturing emotional preference of human subjects, generating machine-readable emotional code and using the code to optimize computerized searching and matching operations between entities is disclosed. The entity can be a human user, a product, or a service. The emotional code can thus be a universal language expressing human emotion that communicates among entities. After understanding the sending parties' emotional profile, the receiving party can adapt its operation to achieve more optimum results.

Abstract: This invention relates to a novel soy isoflavone product with high purities and strong biological activities and the method of producing the same from natural soybeans, soybean materials (i.e. tofu dregs, soy molasses) and other plant sources. The method includes three steps consisting of extraction with an organic solvent, hydrolysis using an acid and crystallization using an antisolvent. The procedure is very simple and thus can be easily adapted for large-scale manufacturing. Moreover, the procedure is able to produce a high yield of total isoflavones at a lower cost. HPLC analysis and E-Screen bioassay reveal that the obtained product not only contains a high content of isoflavone aglycones by weight of dry matter but also exhibits strong estrogenic activity toward human cells. Therefore, the product should be efficacious for relieving menopausal symptoms and other estrogen-deficient diseases and can be used in health care supplements or as additives for foods, beverages or cosmetics.

Abstract: Two hitherto unreported novel triterpene saponins were isolated in substantially pure form from the root of Ilex pubescens. The chemical structures and some properties of the triterpene saponin fraction have been elucidated to possess anti-inflammatory and analgesic activity. These two novel triterpene saponins and the triterpene saponin fraction may be used as pharmaceutical compositions in humans and mammals in need of such treatment.

Abstract: A sign system with a frame and at least one sign. The sign has at least one protruding ridge extending from the backside with the ridge having a narrow neck portion proximate the backside. At least one clamping unit is fixed to the frame with at least one pair of clamps to securely the neck portion of the ridge such that the frame is reversibly but securely fastened to the frame.

Abstract: An electronic device comprises a leadframe attached to a die and embedded in a mold packaging with enhanced adhesion property. The leadframe comprises a bonding surface, a soldering surface, a mold adhesion surface, and a die attachment surface wherein the soldering surface and bonding surface are selectively plated with nickel/palladium/gold. The mold adhesion surface and the die attachment surface are roughened for better attachment to a mold and a die respectively.

Abstract: Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced thereform are also disclosed.

Abstract: The tripeptide Tyrosyl-seryl-valine is disclosed with its use as a pharmaceutical composition in treating a condition whose effects can be reduced by stimulating T-cell transformation and a cell proliferative disorder. A method is also disclosed making a pharmaceutical composition comprising providing the tripeptide Tyrosyl-seryl-valine and mixing said tripeptide with a pharmaceutical acceptable carrier.

Abstract: Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced thereform are also disclosed.

Abstract: The peptide Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (SEQ ID NO.1) is disclosed with its use as a pharmaceutical composition in reducing symptoms of viral disease and stimulating properties of immune system in a subject. A method is also disclosed for making a pharmaceutical composition comprising providing an Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (SEQ ID NO.1) peptide and mixing said peptide with a pharmaceutical acceptable carrier.

Abstract: The present invention is a computer system that analyses the factual and behavioural data of a group of subjects, extracts the common behavioural patterns from the collection, and is capable of forecasting the behaviour of a new subject when his or her factual data are inputted to the system. It does so by first taking a collection of both the factual data and behavioural data from a group of subjects. A clustering engine is employed to compute a set of exemplars that concisely represent the population. Afterwards, the factual data of a subject, and the corresponding behavioural exemplar that he or she belongs, are fed to a learning module so that it can learn the mapping between the subject's factual data and behavioural exemplar. After learning, the system is able to predict the behaviour patterns when factual data of a new subject is presented.

Abstract: A herbal formulation used for treatment of depression and other related disorders comprises the following ingredients, namely Os Draconis, Concha Ostreae, Fructus Tritici Aestivi, Bulbus Lilii, Radix Rehmanniae, Caulis Polygoni Multiflori, Fructus Jujubae, Flos Albiziae, Radix Et. Rhizoma Glycyrrhizae Praeparata Cum Melle, Sclerotium Poriae Circum Radicem Pini, Caulis Bambusae in Taenia, and Rhizoma Zingiberis Recens.

Abstract: The present invention is an extract of the herb Brachystemma calycinum for the amelioration or treatment of pain or discomfort due to, or associated with, osteoarthritis. The extract is obtained by a multi-step extraction process wherein the temperatures of each step never reaches boiling point.